Novartis Investigative Site — Little Rock, Arkansas

Novartis Investigative Site is a clinical research site located in Little Rock, Arkansas, United States 72202.

Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.

Novartis Investigative Site has participated in 40 clinical trials with 1 currently active.

Therapeutic areas: Heart Failure and Reduced Ejection Fraction, Pseudomonas Aeruginosa in Cystic Fibrosis, Asthma.

Sponsors: Novartis Pharmaceuticals, Mylan Inc., Novartis.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Little Rock

Browse all research sites in Arkansas · View every site in Little Rock

Sponsor Feasibility Report

Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis Investigative Site?

Novartis Investigative Site has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis Investigative Site conducted?

Novartis Investigative Site has 40 clinical trials on record, with 1 currently active. Their work covers Heart Failure and Reduced Ejection Fraction, Pseudomonas Aeruginosa in Cystic Fibrosis, Asthma.

Is Novartis Investigative Site accredited by Crixeo Clinical Trials?

Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novartis Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.